Lipid disorders in NIDDM: implications for treatment (Q40832762)

24 September 2017

1 reference

title

Lipid disorders in NIDDM: implications for treatment (English)

1 reference

24 September 2017

Marja-Riitta Taskinen

series ordinal

1

object named as

Taskinen MR

1 reference

24 September 2017

Smith U

2

1 reference

PubMed ID

9845851

24 September 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Journal of Internal Medicine

24 September 2017

1 reference

24 September 2017

244

1 reference

24 September 2017

5

1 reference

24 September 2017

361-370

1 reference

The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome.

24 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Beta-blockers and sudden cardiac death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Lipids and lipoproteins as risk factors for coronary heart disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Lipoprotein heterogeneity and apolipoprotein B metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

The Scandinavian Simvastatin Survival Study (4S) subgroup analysis of diabetic subjects: implications for the prevention of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

The cholesterol controversy is over. Why did it take so long?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00397.X

10.1046/J.1365-2796.1998.00397.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9845851